NCT03966170招募中3 期
Efficacy of Citicoline as Neuroprotector in Preterm; A Randomized Controlled Trial
Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年5月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Number of children with affection of the brain
研究概览
简要总结
Citicoline as neuroprotector in preterm
详细描述
Efficacy of Citicoline as neuroprotector in preterm; A randomized controlled trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- — 至 1 Month（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Preterm on CPAP or ventilator
排除标准
- •Multiple congenital anomalies
研究组 & 干预措施
Citicoline
Experimental
Citicoline as neuroprotector
干预措施: Citicoline (Drug)
Placebo drug
Placebo Comparator
Placebo
干预措施: Placebo oral tablet (Drug)
结局指标
主要结局
Number of children with affection of the brain
时间窗: 6 months
Number of children with affection of the brain
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
招募中
3 期
Citicoline as Neuroprotector in Neonates Exposed to HypoxiaNeonatal HypoxiaNCT03949049Sherief Abd-Elsalam40
已完成
4 期
Efficacy of citicoline as neuroprotector in post cardiac arrest in PICU; A Randomized Controlled TrialNervous System DiseasesPaediatricsPACTR201907742119058faculty of medicine of tanta university60
已完成
不适用
Citicoline in Non-Arteritic Ischemic Optic NeuropathyNon-arteritic Ischemic Optic NeuropathyNCT03758118Fondazione G.B. Bietti, IRCCS40
Unknown
3 期
Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic EncephalopathyHypoxic-Ischemic EncephalopathyNCT03181646Armed Forces Hospital, Pakistan50
进行中（未招募）
2 期
Citicoline in Youth Alcohol Use DisorderAlcohol Use DisorderNCT05870111Medical University of South Carolina56